| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Eterna Therapeutics Inc. | 10%+ Owner | Common Stock | 451K | $1.12M | $2.48 | Dec 2, 2022 | As trustee of family trust |
| Comera Life Sciences Holdings, Inc. | Member of 10% owner group | Common Stock | 1.09M | $77.1K | $0.07 | Dec 27, 2023 | By Trust |
| Eterna Therapeutics Inc. | 10%+ Owner | Common Stock | 205 | $508 | $2.48 | Dec 2, 2022 | Direct |
| Eterna Therapeutics Inc. | 10%+ Owner | Warrants (Right to Purchase) | 672K | Dec 2, 2022 | As trustee of family trust |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CMRA | Comera Life Sciences Holdings, Inc. | Dec 27, 2023 | 0 | $0 | 3 | Jan 8, 2024 | Member of 10% owner group |
| ERNA | Eterna Therapeutics Inc. | Dec 2, 2022 | 2 | $1.19M | 4 | Dec 5, 2022 | 10%+ Owner |
| ERNA | Brooklyn ImmunoTherapeutics, Inc. | Mar 25, 2021 | 0 | $0 | 3 | May 19, 2021 | 10%+ Owner |